Roche boosts forecast for 2013 on promise of expected breast cancer drug

The world’s biggest maker of oncology treatments has applied for regulatory approval of T-DM1, a breast cancer medicine that the FDA will rule on late next month

Go here to read the rest:
Roche boosts forecast for 2013 on promise of expected breast cancer drug

Leave a Reply